Cargando…
Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan
BACKGROUND: Tumors use several immunosuppressive mechanisms to evade immune destruction. Cyclooxygenase-2 (COX-2) expression may be a driver of immunosuppression in breast cancer, but the mechanisms involved remain elusive. COX-2 expression induces the expression of indoleamine 2,3 dioxygenase (IDO)...
Autores principales: | Asghar, Kashif, Loya, Asif, Rana, Iftikhar Ali, Bakar, Muhammad Abu, Farooq, Asim, Tahseen, Muhammad, Ishaq, Muhammad, Rashid, Muhammad Usman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063003/ https://www.ncbi.nlm.nih.gov/pubmed/31759380 http://dx.doi.org/10.31557/APJCP.2019.20.11.3521 |
Ejemplares similares
-
Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
por: Asghar, Kashif, et al.
Publicado: (2019) -
Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients
por: Asghar, Kashif, et al.
Publicado: (2020) -
High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients
por: Asghar, Kashif, et al.
Publicado: (2023) -
Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
por: Asghar, Kashif, et al.
Publicado: (2017) -
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
por: Asghar, Kashif, et al.
Publicado: (2021)